CRISPR-Cas9 System: Opportunities and Concerns

Clinical Chemistry
Stella K VasiliouGerold Schmitt-Ulms

Abstract

No abstract listed.

Citations

Aug 10, 2017·Expert Opinion on Biological Therapy·Kyung-Ah Choi, Sunghoi Hong
Jun 17, 2020·Biotechnology Advances·Binod PrasadMichael Lebert
Aug 10, 2021·Frontiers in Bioengineering and Biotechnology·Alan Raybould

❮ Previous
Next ❯

Related Concepts

Related Feeds

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Related Papers

Archives of Disease in Childhood. Education and Practice Edition
Melody RedmanDavid King
Seikagaku. The Journal of Japanese Biochemical Society
Hiroshi Nishimasu
Zhonghua bing li xue za zhi Chinese journal of pathology
Fang WangWenru Tang
© 2022 Meta ULC. All rights reserved